The market is sleeping on these stocks, but you don't have to.

Equity markets are said to be forward looking. However, sometimes they fail to look far enough into the future by reacting too harshly to the challenges some companies face in the present. The good news is that this often creates opportunities for astute investors to pick up shares of great companies with excellent prospects on the dip.

And that's precisely what we have with Novo Nordisk ( NVO 0.12% ) and Vertex Pharmaceuticals ( VRTX -0.06% ) , two leading drugmakers that have significantly lagged the market this year.

1. Novo Nordisk

After a major slide this year due to worse-than-expected financial results and clinical setbacks, Denmark-based pharmaceutical giant Novo Nordisk is starting to look like a

See Full Page